arrow
T

Takamichi Yokoe

keio university
H指数:11
被引数:341

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment

MUC1-C依赖性在药物耐药的HR+/HER2-乳腺癌中确定了一种新型抗体药物偶联物治疗靶点

2025-04-260
OA
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022

剂量密集化疗在预防性使用培非格司亭的情况下对早期乳腺癌的疗效与安全性:一项基于《2022年G-CSF使用临床实践指南》的系统评价与荟萃分析

2025-02-120
PRE
MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer

MiR-181a靶向STING以驱动BRCA突变的三阴性乳腺癌和卵巢癌的PARP抑制剂耐药

2023-11-069
OAAI
Clinical evaluation of the efficacy and liquid molecular analysis of abemaciclib rechallenge upon progression to abemaciclib combination therapies for ER-positive HER2-negative metastatic breast cancer patients
2022-02-150
PRE
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)
2021-01-029
OAAI